Atrys Health S.A (ATRY) | Stock Overview & Key Data
Atrys Health S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €11.25 on August 30, 2021
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Atrys Health S.A
ATRY
|
222.81M Mid-cap | -3.65% | 7.41% | -3.65% | -14.20% | -0.68% | 1.75% | -42.91% | -69.15% | 81.25% | 81.25% | 81.25% |
|
Pharma Mar S.A
PHM
|
1.68B Large-cap | -2.77% | 9.23% | 17.43% | 27.39% | 23.89% | 30.10% | 151.19% | -0.37% | 186.82% | 180.20% | 30.59% |
| 220.00M Mid-cap | -3.13% | 0.72% | -12.81% | -12.81% | -13.35% | 2.95% | 31.60% | -21.41% | -5.42% | -21.41% | -21.41% | |
| 144.69M Small-cap | 11.05% | 29.80% | 115.38% | 206.25% | 134.73% | 512.50% | 497.56% | 595.04% | 595.04% | 595.04% | 595.04% | |
| 19.30M Small-cap | 8.33% | 13.04% | 30.00% | -27.78% | 30.00% | -16.13% | -21.21% | -70.79% | -91.88% | -88.50% | -88.50% | |
|
Grifols, S.A
GRF
|
6.09B Large-cap | -7.25% | 1.24% | -18.49% | -20.87% | -20.02% | 5.17% | -3.97% | -60.31% | -52.89% | 33.98% | 244.23% |
Ownership & Short Interest
Calculate Your Atrys Health S.A Investment Returns
Long-Term Investment Performance Analysis
Atrys Health S.A stock price in Jul 2016 was €1.60, A €1,000.00 lump sum investment in Atrys Health S.A made 9 years ago would be worth approximately €1,812.50 today, representing a solid return of 81.25%. This translates to an annualized return (CAGR) of 6.28%.
9 Years 9 Months Investment Scenario (Jul 2016 - Apr 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ATRY's 52-week high and low?
- In the last 52 weeks, Atrys Health S.A reached a high of €3.59 (on October 8, 2025) and a low of €2.48 (on June 24, 2025).
- What is the market cap and P/E ratio for ATRY?
- Curious about Atrys Health S.A's size and valuation? Its market capitalization stands at 222.81M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is 27.91.
- Does ATRY pay dividends? If so, what's the yield?
- As for dividends, Atrys Health S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Atrys Health S.A's main competitors or similar companies to consider before investing?
When looking at Atrys Health S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Pharma Mar S.A
PHM1.68B Healthcare Biotechnology 30.10% 151.19% Oryzon Genomics S.A
ORY220.00M Healthcare Biotechnology 2.95% 31.60% Vytrus Biotech S.A
VYT144.69M Healthcare Biotechnology 512.50% 497.56% Biotechnology Assets
BST19.30M Healthcare Biotechnology -16.13% -21.21% Grifols, S.A
GRF6.09B Healthcare Drug Manufacturers - General 5.17% -3.97% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Atrys Health S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Atrys Health S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -27.46%, the Debt to Equity ratio from the most recent quarter is 155.00, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ATRY?
- Looking at Atrys Health S.A's growth, its revenue over the trailing twelve months (TTM) was €144M. Compared to the same quarter last year (YoY), quarterly revenue grew by -75.30%, and quarterly earnings saw a YoY growth of N/A.
- How much of ATRY stock is held by insiders and institutions?
- Wondering who owns Atrys Health S.A stock? Company insiders (like executives and directors) hold about 54.56% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.54%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.